340B Insight

Answering More of Your 340B Questions


Listen Later

In what has become an annual tradition for the podcast, we consulted with 340B Health’s expert staff to answer our listeners’ most pressing 340B questions. As an uncertain and busy year starts for the world of 340B, we want to prepare you by covering your queries about the efforts by drug companies to impose 340B rebates, proposed federal and state legislation on 340B, how Inflation Reduction Act implementation will affect 340B, and more.


340B Rebate Lawsuits Heat Up


So far, five drug companies have sued the Health Resources & Services Administration to challenge HRSA’s rejections of their backend rebate proposals. 340B Health Vice President of Legal and Policy Amanda Nagrotsky notes that a rebate model would harm 340B hospitals through delayed access to 340B savings and potentially denials of legitimate rebate claims based on drugmaker interpretations of 340B rules. We recorded this episode just before 340B Health filed a motion to intervene as a defendant in the Johnson & Johnson (J&J) rebate lawsuit against HRSA.


Lawmakers Eye Ways To Protect or Cut 340B


The new year means a new Congress and the start of new state legislative sessions. 340B Health Senior Vice President of Government Relations Tom O’Donnell notes that members of Congress have floated potential reductions in what the federal government pays for 340B drugs to help fund new spending priorities outside of health care, though it is unclear how seriously they are considering those options. 340B Health Vice President of Legal and Policy Greg Doggett reports that several states are considering new contract pharmacy or payment nondiscrimination protections for 340B hospitals, but others have introduced proposed new mandates for covered entities. 


Price Caps Will Apply to More Medicare Drugs


The list of drugs eligible for Medicare price caps will grow to 25 starting in 2027 under the Inflation Reduction Act, which will have implications for 340B savings on those drugs. 340B Health Research and Policy Analytics Manager Claudia Escue notes that popular weight loss and diabetes drugs like Ozempic and Wegovy have made the price cap list because of how much they cost Medicare. 340B Health is tracking how these price caps might lower 340B savings and have submitted letters to Medicare officials to represent other hospital concerns about the implementation of the IRA.


Resources:

  1. 340B Health Files Motion To Intervene in J&J Rebate Lawsuit
  2. Option To Cut Commercial Pay Rates for 340B Drugs Is on Draft Congressional Budget “Menu”
  3. Medicare Expands List of Drugs Subject to Price Caps, Decreased 340B Savings
  4. 340B Coalition Winter Conference Registration 
...more
View all episodesView all episodes
Download on the App Store

340B InsightBy 340B Health

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

21 ratings


More shows like 340B Insight

View all
WSJ Your Money Briefing by The Wall Street Journal

WSJ Your Money Briefing

1,714 Listeners

The NPR Politics Podcast by NPR

The NPR Politics Podcast

25,770 Listeners

Up First from NPR by NPR

Up First from NPR

55,990 Listeners

KFF Health News' 'What the Health?' by KFF Health News

KFF Health News' 'What the Health?'

480 Listeners

The Readout Loud by STAT

The Readout Loud

317 Listeners

Suze Orman's Women & Money (And Everyone Smart Enough To Listen) by Suze Orman Media

Suze Orman's Women & Money (And Everyone Smart Enough To Listen)

4,398 Listeners

On Purpose with Jay Shetty by iHeartPodcasts

On Purpose with Jay Shetty

26,938 Listeners

Morning Brew Daily by Morning Brew

Morning Brew Daily

2,963 Listeners

The Daily Dad by Daily Dad

The Daily Dad

581 Listeners

The Working Genius Podcast with Patrick Lencioni by Patrick Lencioni

The Working Genius Podcast with Patrick Lencioni

361 Listeners

Pharmacy Innovators Podcast by Visante Consulting

Pharmacy Innovators Podcast

7 Listeners

340B Unscripted by SpendMend Pharmacy

340B Unscripted

32 Listeners

WSJ's Take On the Week by The Wall Street Journal

WSJ's Take On the Week

126 Listeners

Inside 340B Report by 340B Report

Inside 340B Report

3 Listeners

340Banter Podcast by FQHC 340B Compliance

340Banter Podcast

7 Listeners